VGD071 是一种以sortilin为靶向的化合物，是使用小鼠乳腺癌模型进行研究的有希望的候选药物。

VGD071, a sortilin -targeting compound, is a promising candidate for future studies using mouse breast cancer models.

C32H41N3O4S2

595.82

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years